327 related articles for article (PubMed ID: 28766120)
21. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
23. Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.
Oschlies I; Kohler CW; Szczepanowski M; Koch K; Gontarewicz A; Metze D; Hillen U; Richter J; Spang R; Klapper W
J Invest Dermatol; 2017 Nov; 137(11):2450-2453. PubMed ID: 28684330
[No Abstract] [Full Text] [Related]
24. Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2013 Jan; 88(1):73-6. PubMed ID: 23379008
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines.
Pedretti S; Urpis M; Leali C; Borghetti P; Baushi L; Sala R; Tucci A; Greco D; Pasinetti N; Triggiani L; Rossi G; Calzavara-Pinton P; Magrini SM; Buglione M
Tumori; 2018 Oct; 104(5):394-400. PubMed ID: 28218382
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
27. What is new about primary cutaneous B cell lymphomas.
Blanchard M; Hoetzenecker W; Blanchard G; Guenova E
Ital J Dermatol Venerol; 2023 Jun; 158(3):205-216. PubMed ID: 37278499
[TBL] [Abstract][Full Text] [Related]
28. Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals.
Jaffe ES
Mod Pathol; 2020 Jan; 33(Suppl 1):96-106. PubMed ID: 31653979
[TBL] [Abstract][Full Text] [Related]
29. Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
Hamilton SN; Wai ES; Tan K; Alexander C; Gascoyne RD; Connors JM
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):719-25. PubMed ID: 24001373
[TBL] [Abstract][Full Text] [Related]
30. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ;
Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous B-cell lymphomas - pathogenesis, diagnostic workup, and therapy.
Nicolay JP; Wobser M
J Dtsch Dermatol Ges; 2016 Dec; 14(12):1207-1224. PubMed ID: 27992127
[TBL] [Abstract][Full Text] [Related]
32. Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia.
Swerdlow SH
Am J Clin Pathol; 2004 Dec; 122 Suppl():S98-109. PubMed ID: 15690646
[TBL] [Abstract][Full Text] [Related]
33. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
Hallermann C; Niermann C; Fischer RJ; Schulze HJ
Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
[TBL] [Abstract][Full Text] [Related]
34. Primary Cutaneous Follicle Center Lymphoma.
Skala SL; Hristov B; Hristov AC
Arch Pathol Lab Med; 2018 Nov; 142(11):1313-1321. PubMed ID: 30407851
[TBL] [Abstract][Full Text] [Related]
35. [Therapy of primary cutaneous B-cell lymphomas].
Zenahlik P; Fink-Puches R; Kapp KS; Kerl H; Cerroni L
Hautarzt; 2000 Jan; 51(1):19-24. PubMed ID: 10663035
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous B-cell lymphoma].
Cortés B; Prins C
Rev Med Suisse; 2014 Apr; 10(424):738, 740-3. PubMed ID: 24772806
[TBL] [Abstract][Full Text] [Related]
37. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients.
Caimi PF; William BM; Silva Rondon CH; Fu P; Cooper BW; Campagnaro EL; Gerson SL; Reese-Koc J; Fox R; Creger RJ; de Lima M; Lazarus HM
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1926-31. PubMed ID: 26087475
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea.
Kim MJ; Hong ME; Maeng CH; Jung HA; Hong JY; Choi MK; Kim SJ; Ko YH; Kim WS
Int J Hematol; 2015 Mar; 101(3):273-8. PubMed ID: 25552248
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma.
Vermeesch J; Ramirez J; Lafond A
Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]